Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Feb, 2019 | Pages:
90 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
The U.S. atherectomy devices market size is expected to reach USD 626.1 million by 2025 expanding at a CAGR of 6.6%, according to a new report by Grand View Research, Inc. The regional market is expected to witness lucrative growth due to the rising prevalence of target diseases and preference for endovascular procedures. Moreover, rising demand for minimally invasive procedure will boost the market growth. Such procedures are less painful and allow quicker recovery than invasive procedures. Other advantages, such as higher patient satisfaction owing to fewer incision wounds, few post-surgical complications, and low mortality rates, are also driving the atherectomy devices market growth. Technological advancements allowing early diagnosis are also likely to augment the market growth in the near future. For instance, in January 2017, Medtronic received CE mark approval for HawkOne directional atherectomy system for treating patients suffering from Peripheral Artery Disease (PAD). Further key findings from the study suggest: • Adoption of atherectomy increased sharply in the past due to increased reimbursement for the procedure. According to Elsevier Inc., there was a rise in atherectomy volume for Medicare beneficiaries to 76% in 2011-2015 • Directional atherectomy devices accounted for the largest share of the market in 2017 as the device exhibited 95% successful removal of lesions and 94% of patients did not exhibit adverse effects • Office-Based Labs (OBLs) is anticipated to be the fastest-growing segment in the forecast period due to a greater number of Peripheral Vascular Interventional (PVI) procedures being performed in this setting • In addition, lesser number of complications and follow-up procedures lowers the cost and increases the adoption of new technologies delivering better health outcomes, which is anticipated to propel the market growth in the coming years • Several ongoing trials and their positive results facilitate penetration of novel technologies. For instance, in March 2017, Cardiovascular Systems, Inc. enrolled for its latest clinical trial, ECLIPSE, which was perceived to be the largest trial conducted to study coronary atherectomy • Some of the key companies are Spectranetics Corp.; Boston Scientific Corp.; Cardinal Health, Inc.; Straub Medical AG; Terumo Medical Corp.; Cardiovascular Systems, Inc.; Medtronic PLC; Avinger, Inc.; ST. JUDE MEDICAL, Inc.
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Increasing prevalence of target diseases
3.1.1.2 Preference to minimally invasive procedures
3.1.2 Market restraint analysis
3.1.2.1 Lack of level 1 evidence for atherectomy
3.1.2.2 Lack of technical training for the procedure
3.1.2.3 Significant adoption of alternative therapies
3.2 Penetration & Growth Prospects Mapping
3.3 U.S. Atherectomy Devices Market - PESTLE Analysis
3.4 Industry Analysis - Porter's
3.5 U.S. Atherectomy Devices: Regulatory Scenario
3.6 U.S. Atherectomy Devices Market: Reimbursement Scenario
3.7 Key Clinical Trials & Studies
3.7.1 Opinions/Views on Key Clinical Trials and Their Impact on the Market and Customer
3.8 U.S. Peripheral Atherectomy: Number of Procedures
Chapter 4 U.S. Atherectomy Devices Market: Type Estimates & Trend Analysis
4.1 U.S. Atherectomy Devices Market: Type Movement Analysis
4.2 Directional Atherectomy Devices
4.2.1 Directional atherectomy devices market, 2014 - 2025 (USD Million)
4.3 Rotational Atherectomy Devices
4.3.1 Rotational atherectomy market, 2014 - 2025 (USD Million)
4.4 Orbital Atherectomy Devices
4.4.1 Orbital atherectomy devices market, 2014 - 2025 (USD Million)
4.5 Laser Atherectomy Devices
4.5.1 Laser atherectomy devices market, 2014 - 2025 (USD Million)
Chapter 5 U.S. Atherectomy Devices Market: End Use Estimates & Trend Analysis
5.1 U.S. Atherectomy Devices Market: End Use Movement Analysis
5.2 In-Patient Facility
5.2.1 In-patient facility market, 2014 - 2025 (USD Million)
5.3 Office-Based Labs (OBLs)
5.3.1 Office-based labs (OBLs) market, 2014 - 2025 (USD Million)
5.4 Out-Patient facility
5.4.1 Out-patient facility, 2014 - 2025 (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Competitive Landscape: Market Position Analysis
6.3 Company Profiles
6.3.1 Boston Scientific Corporation
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 SWOT analysis
6.3.1.4 Product benchmarking
6.3.1.5 Strategic initiatives
6.3.2 Cardiovascular Systems, Inc.
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 SWOT analysis
6.3.2.4 Product benchmarking
6.3.2.5 Strategic initiatives
6.3.3 Medtronic
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 SWOT analysis
6.3.3.4 Product benchmarking
6.3.3.5 Strategic initiatives
6.3.4 Spectranetics
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 SWOT analysis
6.3.4.4 Product benchmarking
6.3.4.5 Strategic initiatives
6.3.5 Avinger
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 ST. JUDE MEDICAL
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 SWOT analysis
6.3.6.4 Product benchmarking
6.3.7 Cardinal Health (Cordis)
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 SWOT analysis
6.3.7.4 Product benchmarking
6.3.7.5 Strategic initiatives
6.3.8 Terumo Medical Corporation
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 SWOT analysis
6.3.8.4 Product benchmarking
6.3.8.5 Strategic initiatives
Chapter 7 Recommendations
7.1 KOL Views
7.2 Recommendations
List of Tables TABLE 1 Atherectomy devices comparison TABLE 2 Comparison of cutting balloon angioplasty vs rotational atherectomy TABLE 3 Procedure codes and physician reimbursement for endovascular procedures, 2018 TABLE 4 Ambulatory surgery center reimbursement for endovascular procedures, 2018 TABLE 5 Medicare national average payments, 2017 TABLE 6 Medicare reimbursement by clinical setting, 2016 TABLE 7 Medicare reimbursement comparison, 2014 TABLE 8 Patient selection criteria TABLE 9 Patient selection criteria TABLE 10 Patient selection criteria TABLE 11 List of in-patient facility performing atherectomy in the U.S. TABLE 12 Top five states performing endovascular procedures including atherectomy in OBLs, 2016
List of Figures FIG. 1 Market research process FIG. 2 Information procurement FIG. 3 Primary research pattern FIG. 4 Market research approaches FIG. 5 Value chain-based sizing & forecasting FIG. 6 QFD modeling for market share assessment FIG. 7 Market summary 2018 (USD Million) FIG. 8 Market trends & outlook FIG. 9 Market segmentation & scope FIG. 10 Market driver relevance analysis (Current & future impact) FIG. 11 Prevalence of PAD (%) by age group (years), 2016 FIG. 12 Market restraint relevance analysis (Current &future impact) FIG. 13 Penetration & growth prospect mapping FIG. 14 U.S. atherectomy devices market - PESTLE analysis FIG. 15 Porter's Five Forces Analysis FIG. 16 U.S. atherectomy devices market type outlook key takeaways FIG. 17 U.S. atherectomy devices: Type movement analysis FIG. 18 Directional atherectomy devices market, 2014 - 2025 (USD Million) FIG. 19 Above knee atherosclerosis FIG. 20 Below knee atherosclerosis FIG. 21 Rotational atherectomy market, 2014 - 2025 (USD Million) FIG. 22 Orbital atherectomy devices market, 2014 - 2025 (USD Million) FIG. 23 Laser atherectomy devices market, 2014 - 2025 (USD Million) FIG. 24 U.S. atherectomy devices market end-use outlook key takeaways FIG. 25 U.S. atherectomy devices: End-use movement analysis FIG. 26 In-patient facility market, 2014 - 2025 (USD Million) FIG. 27 Office-based labs (OBLs) market, 2014 - 2025 (USD Million) FIG. 28 Out-patient facility market, 2014 - 2025 (USD Million) FIG. 29 Strategy framework FIG. 30 U.S. atherectomy devices market: Heat map analysis
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
